Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))

Philip Raskin; L. Klaff; J. McGill; S. A. South; P. Hollander; N. Khutoryansky; P. M. Hale

doi:10.2337/diacare.26.9.2708

Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))

Philip Raskin, L. Klaff, J. McGill, S. A. South, P. Hollander, N. Khutoryansky, P. M. Hale

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2708
Number of pages	1
Journal	Diabetes care
Volume	26
Issue number	9
DOIs	https://doi.org/10.2337/diacare.26.9.2708
State	Published - Sep 1 2003

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Access to Document

10.2337/diacare.26.9.2708

Cite this

Raskin, P., Klaff, L., McGill, J., South, S. A., Hollander, P., Khutoryansky, N., & Hale, P. M. (2003). Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068)). Diabetes care, 26(9), 2708. https://doi.org/10.2337/diacare.26.9.2708

Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068)). / Raskin, Philip; Klaff, L.; McGill, J. et al.
In: Diabetes care, Vol. 26, No. 9, 01.09.2003, p. 2708.

Research output: Contribution to journal › Comment/debate › peer-review

Raskin, P, Klaff, L, McGill, J, South, SA, Hollander, P, Khutoryansky, N & Hale, PM 2003, 'Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))', Diabetes care, vol. 26, no. 9, pp. 2708. https://doi.org/10.2337/diacare.26.9.2708

@article{06601d74a22f4ccf965de8b18656deff,

title = "Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))",

author = "Philip Raskin and L. Klaff and J. McGill and South, {S. A.} and P. Hollander and N. Khutoryansky and Hale, {P. M.}",

year = "2003",

month = sep,

day = "1",

doi = "10.2337/diacare.26.9.2708",

language = "English (US)",

volume = "26",

pages = "2708",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "9",

}

TY - JOUR

T1 - Erratum

T2 - Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))

AU - Raskin, Philip

AU - Klaff, L.

AU - McGill, J.

AU - South, S. A.

AU - Hollander, P.

AU - Khutoryansky, N.

AU - Hale, P. M.

PY - 2003/9/1

Y1 - 2003/9/1

UR - http://www.scopus.com/inward/record.url?scp=0042824219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042824219&partnerID=8YFLogxK

U2 - 10.2337/diacare.26.9.2708

DO - 10.2337/diacare.26.9.2708

M3 - Comment/debate

AN - SCOPUS:0042824219

SN - 0149-5992

VL - 26

SP - 2708

JO - Diabetes care

JF - Diabetes care

IS - 9

ER -

Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this